POMGNT1 and neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan: For example, pomgnt1 ZKOs have only shown retinal degeneration at 6 mpf while mouse models have phenotypes consistent with dystroglycanopathy [34].